Find out more about our work to increase access to innovative healthcare products. Read our latest press releases and dive deeper with insight articles and primers on innovative finance for healthcare.
Nigeria is ramping up the use of a test which can detect both HIV and syphilis simultaneously. But why is this test so vital to the health of mothers and their babies?
New lower prices negotiated as partners aim to increase access to short-course tuberculosis preventive treatments.
Self-testing can play an important role in closing the gap between people living with HIV and those who know their status.
MedAccess join partners to speed up equitable access to injectable cabotegravir for HIV pre-exposure prophylaxis (PrEP).
MedAccess, the Clinton Health Access Initiative (CHAI), and Wondfo announced an agreement to make Wondfo’s HIV self-test available for US$1.
MedAccess today publishes its 2021 Annual Review, setting out how our guarantees helped accelerate access to vital healthcare products in a challenging year for global health.
MedAccess has reaffirmed its commitment increase access to COVID-19 vaccines via a $100m guarantee for COVAX
Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to help meet country demand for COVID-19 vaccines
Results from a study in Tanzania show the Interceptor® G2 mosquito net to be highly effective at reducing malaria cases
MedAccess has welcomed Hologic’s decision to make its Aptima® SARS-CoV-2 Assay available to low- and middle-income countries under the terms of the Global Access Initiative.
MedAccess is pleased to announce the appointment of Violet Mordichai to the position of apprentice to the Board.
Everything you need to know about the decision by Gavi, the Vaccine Alliance to fund the world’s first mass malaria immunisation programmes using the ground-breaking RTS,S/AS01e vaccine.
MedAccess has welcomed the decision by Gavi, the Vaccine Alliance to fund the world’s first mass malaria immunisation programmes using the ground-breaking RTS,S/AS01e vaccine.
HIV viral load testing is the best way for doctors to know if the treatment they prescribe is effective. But access to viral load testing technology is far from equal.
On November 15, the Clinton Health Access Initiative (CHAI), MedAccess, and SD Biosensor announced a partnership to increase access to rapid diagnostic tests for syphilis and HIV.
MedAccess, CHAI and SD Biosensor announce partnership to make dual rapid test for syphilis and HIV available for under US$1 in over 100 low- and middle-income countries
Evans Mburu, our implementation executive, knows first-hand TB’s devastating impact. Watch Evans share his story about taking TB treatment.
The longer a mosquito population is exposed to a single class of insecticides, the longer it has had to build resistance. Dr. Tom McLean from IVCC explores three insecticide tools at market and in development to battle resistance.
Vicky will lead on all aspects of financial management, control and reporting and she joins MedAccess' Senior Management Team.
MedAccess' volume guarantee will help increase availability of an innovative treatment for latent tuberculosis.
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.
New malaria control technologies are tackling the problem of insecticide resistance in mosquitos. Dr. Tom McLean from IVCC discusses how to get these new tools to the people who need them.
MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.
Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world
Ghana will begin its COVID-19 immunisation campaign using syringes provided through MedAccess' support for UNICEF.
Through the Global Access Initiative, we are helping to increase access viral load testing through the Panther platform. Ahead of World AIDS Day 2020, two laboratory technicians in Kenya and Zambia told us how Panther is helping them to better serve patients.
Michael joined an ODI panel to assess the immediate development finance institutions' (DFI) response to the COVID-19 pandemic and how DFI’s could support public sector investment in the health sector.
Considerable progress has been made to improve girls’ health and to empower and educate them to make safer decisions about their bodies. Here are three major concerns for the health of girls around the world.
Our 2019 Annual Report highlights how our guarantees secured lower prices and supported sustainable access to healthcare products for people living in underserved communities.
New support for UNICEF to secure vital COVID-19 medical products, including diagnostic tests and clinical management supplies, for low- and middle-income countries.
Academic and scientific communities, and pharmaceutical companies, have moved away from business as usual in the pursuit of medical products to tackle coronavirus.
Whilst the progress against infectious diseases has been nothing short of remarkable, the burden of non-communicable diseases (NCDs) has increased.
MedAccess is pleased to announce the appointment of Hema Srinivasan as the social finance company’s new Chief Access Officer. Hema will take up her new role in March 2020.
The price of new BASF Interceptor® G2 mosquito nets will be reduced by 40% for underserved communities thanks to a new MedAccess partnership
MedAccess has been invited to showcase how a social finance company can accelerate the delivery of new and better products in the fight against diseases.
An independent ranking of 20 of the world’s leading pharmaceutical companies on their efforts to improve access to medicine in low- and middle-income countries.
The importance of making routine HIV tests more accessible as part of the effort to reach the U.N.’s ambitious goal to eliminate HIV transmission by the year 2030.
The Hologic Global Access Initiative was launched at the International AIDS Society Conference in July 2018, setting a new standard for affordable and transparent pricing.
Despite the efficacy and availability of quality-assured implants, evidence from national family planning programs has suggested a significant unmet need.